News

According to data collected by Thomson, the Toronto-based financial-information provider, the companies raised their US wholesale prices by 9% on their 10 top-selling medicines in 2007, more than

The UK research team that was led by Helen Sammons, a clinical associate professor in child health at the University of Nottingham’s Medical School, carried out a detailed

Sun Pharma’s product is being sold in the US by its marketing partner Caraco Pharmaceutical Laboratories. Sun Pharma had received a FDA approval for this earlier in March

The study will be stopped early because there is unequivocal evidence of a reduction in cardiovascular morbidity and mortality amongst patients who received Crestor when compared to placebo.

The trial is an eight-week, double-blind, placebo-controlled, exploratory study being conducted in 20 sites in the US. It will assess the efficacy and tolerability of rufinamide in up

Positive improvements were observed on several efficacy endpoints including tumour response rate and time to tumour progression. The primary efficacy variable was tumour response rate as assessed by

LY450139 is being tested to see if it can slow the progression associated with Alzheimer’s disease by inhibiting gamma-secretase, an enzyme that can create a sticky protein called

Teva will acquire Bentley, which at closing will consist solely of the generic pharmaceutical operations, for an aggregate cash purchase price of approximately $360 million. Shareholders of Bentley

Under the terms of the agreement, Gene Bridges has licensed the Red/ET technology to Genencor for the purpose of genetically engineering recombinant micro-organisms for use in industrial applications.